Get App
Download App Scanner
Scan to Download
Advertisement

Archean Chemical Shares May Rally Up To 35%; ICICI Securities Sees Attractive Risk-Reward — Check Target Price

Archean is in the advance stages of starting construction on its SiC semiconductor facility and it has partnered with multiple ecosystem players to support its ramp-up, and the company will be the sole player with SiC fabrication and ATMP facility in India.

Archean Chemical Shares May Rally Up To 35%; ICICI Securities Sees Attractive Risk-Reward — Check Target Price
Archean Chemical is ICICI Securities top pick in the speciality chemicals space and offers a highly favourable risk-reward profile.
(Photo: NDTV Profit/ AI generated image)
STOCKS IN THIS STORY
Archean Chemical Industries Ltd
--

NDTV Profit's special research section collates quality and in-depth equity and economy research reports from across India's top brokerages, asset managers and research agencies. These reports offer NDTV Profit's subscribers an opportunity to expand their understanding of companies, sectors and the economy.

ICICI Securities Report

Archean Chemical Industries Ltd. is ICICI Securities top pick in the speciality chemicals space and offers a highly favourable risk-reward profile.

Archean is in the advance stages of starting construction on its SiC semiconductor facility and it has partnered with multiple ecosystem players to support its ramp-up. The company will be the sole player with SiC fabrication and ATMP facility in India.

Since SiC semiconductor demand is incredibly strong, it offers a massive import substitution market.

ALSO READ: Stock To Buy: Nippon AMC Poised For Growth, Says Motilal Oswal, Sees Up To 18% Upside — Check Target Price

Furthermore, Archean's core business is showing signs of revival with improved bromine production and normalisation of prices after three weak years. Although the salt business is facing transient challenges, it is likely to show improvement in H2 FY27.

Core business has the potential to positively surprise from SOP and bromine derivative biz. More importantly, the brokerage believes current market price does not assign any value to these new businesses. Hence the brokerage has maintained 'Buy' rating on the stock.

Click on the attachment to read the full report:

Isec Archean .pdf
VIEW DOCUMENT

DISCLAIMER

This report is authored by an external party. NDTV Profit does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of NDTV Profit.

Users have no license to copy, modify, or distribute the content without permission of the Original Owner.

Essential Business Intelligence, Sharp Market Insights, Practical Personal Finance Advice, Daily Fuel, Gold and Silver Prices and Latest Stories — On NDTV Profit.

To continue reading this story
You must be an existing Premium User

Newsletters

Update Email
to get newsletters straight to your inbox
⚠️ Add your Email ID to receive Newsletters
Note: You will be signed up automatically after adding email

News for You

Set as Trusted Source
on Google Search
Add NDTV Profit As Google Preferred Source
Loading PDF...
Listen to the latest songs, only on JioSaavn.com